- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07922304
Aroma Inhalation and Exam Stress: Role of Emotional Intelligence and Stress Biomarkers
Effect of Aroma Inhalations (Thyme and Juniper) on Exam Stress and Apelin and Cerebral (BDNF) Stress Response (GRP78) According to Emotional Intelligence Levels and Stress Management Skills
This study is an interventional investigation aiming to evaluate the physiological effects of thyme (Thymus vulgaris) and juniper (Juniperus communis) essential oil aroma inhalation on examination stress in medical students. The research assesses participants' emotional intelligence and exam anxiety levels, and analyzes changes in salivary apelin, BDNF, and GRP78 levels using the ELISA method before and after the aromatherapy intervention.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Study Purpose: This study aims to investigate the effects of aroma inhalations (thyme and juniper) on exam stress, adipokines (apelin), neurotrophic factors (BDNF), and endoplasmic reticulum stress responses (GRP78) based on emotional intelligence and exam anxiety levels in medical students. Methods: The study is a three-arm, randomized, controlled interventional investigation conducted on healthy volunteer medical students. Saliva samples are collected before inhalation and immediately after the 15-minute intervention. The ELISA technique is utilized to determine salivary apelin, BDNF, and GRP78 levels.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Altindag
-
Ankara, Altindag, Turquía (Türkiye), 06050
- Ankara Medipol University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
Being willing to participate in the research, being a medical student, not having a cardiovascular disease, not having any allergies to odors, not being pregnant, not having any respiratory system diseases (such as asthma, COPD, etc.), not having any condition that prevents smelling, not using any medication that affects heart rate and blood pressure, and not having any psychiatric illness.
Exclusion Criteria:
The communication barrier, incomplete filling of forms, menstruation in girls, allergy to the scents of thyme and juniper oil, and the occurrence of any side effects during the application.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Juniper Aromatherapy Group
Participants inhale juniper essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation. |
Participants inhale juniper essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters. |
|
Experimental: Thyme Aromatherapy Group
Participants inhale thyme essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation. |
Participants inhale thyme essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Salivary Apelin Levels
Periodo de tiempo: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary apelin levels will be measured to evaluate the metabolic and neuroendocrine response to aroma inhalation. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
|
Change in Salivary BDNF Levels
Periodo de tiempo: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary BDNF levels will be measured as a neurotrophic and physiological stress indicator. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
|
Change in Salivary GRP78 Levels
Periodo de tiempo: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary GRP78 levels will be measured to monitor cellular endoplasmic reticulum stress responses. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- AROMA-MED-2025-02
- E-81477236-604.01.01-3006 (Otro identificador: Ethics Committee Approval Number, Ankara Medipol University Faculty of Medicine, Turkey)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
The individual participant data (IPD) will not be shared due to ethical considerations and institutional restrictions.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .